Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Immunocore Holdings (IMCR) EBT Margin (2023 - 2025)

Immunocore Holdings (IMCR) has disclosed EBT Margin for 3 consecutive years, with 15.12% as the latest value for Q4 2025.

  • Quarterly EBT Margin rose 1441.0% to 15.12% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 4.77% through Dec 2025, up 1229.0% year-over-year, with the annual reading at 4.77% for FY2025, 1229.0% up from the prior year.
  • EBT Margin hit 15.12% in Q4 2025 for Immunocore Holdings, down from 0.29% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 7.59% in Q3 2024 to a low of 36.55% in Q4 2023.
  • Historically, EBT Margin has averaged 15.53% across 3 years, with a median of 14.28% in 2024.
  • Biggest YoY gain for EBT Margin was 4063bps in 2025; the steepest drop was -730bps in 2025.
  • Year by year, EBT Margin stood at 36.55% in 2023, then grew by 19bps to 29.53% in 2024, then skyrocketed by 49bps to 15.12% in 2025.
  • Business Quant data shows EBT Margin for IMCR at 15.12% in Q4 2025, 0.29% in Q3 2025, and 9.9% in Q2 2025.